ISSN 2639-9431
Vol. 1, Issue 3, 2018September 25, 2018 EDT
Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
Adam Friedman, Kenny Ye, Alicia Rodriguez-Gabin, Joshua Nosanchuk, Joel Friedman, Alan Alfieri, Mahantesh Navanti, Angelo Landriscina, Jamie Rosen, David Schairer, Joy Makdisi, Brandon Adler, Aimee Krausz, Hayley McDaid,
Articles in Vol. 1, Issue 3, 2018
Vol. 1, Issue 3, 2018
- Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancerMattaka KhongkowTzu-Yu LiuStacey BartlettWaleed M. HusseinReshma NevagiZhongfan JiaMichael J. MonteiroJames WellsUracha Rungsardthong RuktanonchaiMariusz SkwarczynskiIstvan Toth
- Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to DoxorubicinAdam FriedmanKenny YeAlicia Rodriguez-GabinJoshua NosanchukJoel FriedmanAlan AlfieriMahantesh NavantiAngelo LandriscinaJamie RosenDavid SchairerJoy MakdisiBrandon AdlerAimee KrauszHayley McDaid
- Specific molecular recognition as a strategy to delineate tumor margin using topically applied fluorescence embedded nanoparticlesWellington PhamShawn BartonBo LiMichael SiutaVaibhav A. JanveJessica SongClinton M. HoltTakumi TomonoMasami UkawaHironori KumagaiEtsuo TobitaKevin WilsonShinji Sakuma
- Plasma samples from mouse strains and humans demonstrate different in vitro susceptibilities to complement activationBarry W NeunGábor SzénásiJános SzebeniMarina Dobrovolskaia
Friedman, Adam, Kenny Ye, Alicia Rodriguez-Gabin, Joshua Nosanchuk, Joel Friedman, Alan Alfieri, Mahantesh Navanti, et al. 2018. “Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin.” Precision Nanomedicine 1 (3): 173–82. https://doi.org/10.33218/prnano1(3).181029.1.